Dhamirah Nazihah Mohd Nasiruddin: Bridging Clinical Suspicion and Laboratory Diagnosis in TMA
Dhamirah Nazihah Mohd Nasiruddin, Head of Haematology Unit, Quality Manager for the Department of Pathology and Laboratory Medicine at Sultan Ahmad Shah Medical Centre IIUM, shared a post on LinkedIn:
“Two countries, one shared question: how do we catch TMAs early?
As a panellist on yesterday’s Navigating the TMA: Clinical Context and Laboratory Pathways, I learnt from Dr Danny Hsu (Liverpool Hospital, Sydney) how Australia moves from clinical suspicion to TMA screening and then confirmation testing: a clear, stepwise pathway worth reflecting on locally.
Dr Veena Selvaratnam (Hospital Ampang) brought a valuable view from the MOH haemostasis referral laboratory.
Dr Hsu is also as warm and funny as he is knowledgeable.
My thanks to Dr Sri Rahayu Sabtu for chairing, and to the Malaysian Medical Association and the AstraZeneca team.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 09:40Diego Martin Rabasedas: Celebrating National Voluntary Blood Donor Day in Argentina
-
Nov 11, 2026, 09:32Nathan Connell: Can a Thrombophilic Factor VIII Variant Inform Future Hemophilia A Therapies?
-
Nov 11, 2026, 09:24Amer Zeidan: Highlights from the 2026 New England Hematologic Disease Symposium
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles